Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 3
2008 2
2009 3
2010 8
2011 7
2012 10
2013 13
2014 22
2015 15
2016 9
2017 12
2018 17
2019 15
2020 22
2021 30
2022 25
2023 19
2024 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

214 results

Results by year

Filters applied: . Clear all
Page 1
Targeting the NLRP3 inflammasome in cardiovascular diseases.
Toldo S, Mezzaroma E, Buckley LF, Potere N, Di Nisio M, Biondi-Zoccai G, Van Tassell BW, Abbate A. Toldo S, et al. Among authors: van tassell bw. Pharmacol Ther. 2022 Aug;236:108053. doi: 10.1016/j.pharmthera.2021.108053. Epub 2021 Dec 11. Pharmacol Ther. 2022. PMID: 34906598 Free PMC article. Review.
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19.
Bonaventura A, Vecchié A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, Dentali F, Montecucco F, Massberg S, Levi M, Abbate A. Bonaventura A, et al. Among authors: van tassell bw. Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9. Epub 2021 Apr 6. Nat Rev Immunol. 2021. PMID: 33824483 Free PMC article. Review.
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease.
Talasaz AH, Sadeghipour P, Ortega-Paz L, Kakavand H, Aghakouchakzadeh M, Beavers C, Fanikos J, Eikelboom JW, Siegal DM, Monreal M, Jimenez D, Vaduganathan M, Castellucci LA, Cuker A, Barnes GD, Connors JM, Secemsky EA, Van Tassell BW, De Caterina R, Kurlander JE, Aminian A, Piazza G, Goldhaber SZ, Moores L, Middeldorp S, Kirtane AJ, Elkind MSV, Angiolillo DJ, Konstantinides S, Lip GYH, Stone GW, Cushman M, Krumholz HM, Mehran R, Bhatt DL, Bikdeli B. Talasaz AH, et al. Among authors: van tassell bw. Nat Rev Cardiol. 2024 Aug;21(8):574-592. doi: 10.1038/s41569-024-01003-3. Epub 2024 Mar 20. Nat Rev Cardiol. 2024. PMID: 38509244 Review.
Cirrhotic cardiomyopathy.
Zardi EM, Abbate A, Zardi DM, Dobrina A, Margiotta D, Van Tassell BW, Afeltra A, Sanyal AJ. Zardi EM, et al. Among authors: van tassell bw. J Am Coll Cardiol. 2010 Aug 10;56(7):539-49. doi: 10.1016/j.jacc.2009.12.075. J Am Coll Cardiol. 2010. PMID: 20688208 Free article. Review.
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
INSPIRATION Investigators; Sadeghipour P, Talasaz AH, Rashidi F, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M, Sezavar SH, Payandemehr P, Dabbagh A, Moghadam KG, Jamalkhani S, Khalili H, Yadollahzadeh M, Riahi T, Rezaeifar P, Tahamtan O, Matin S, Abedini A, Lookzadeh S, Rahmani H, Zoghi E, Mohammadi K, Sadeghipour P, Abri H, Tabrizi S, Mousavian SM, Shahmirzaei S, Bakhshandeh H, Amin A, Rafiee F, Baghizadeh E, Mohebbi B, Parhizgar SE, Aliannejad R, Eslami V, Kashefizadeh A, Kakavand H, Hosseini SH, Shafaghi S, Ghazi SF, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Piazza G, Kirtane AJ, Van Tassell BW, Dobesh PP, Stone GW, Lip GYH, Krumholz HM, Goldhaber SZ, Bikdeli B. INSPIRATION Investigators, et al. Among authors: van tassell bw. JAMA. 2021 Apr 27;325(16):1620-1630. doi: 10.1001/jama.2021.4152. JAMA. 2021. PMID: 33734299 Free PMC article. Clinical Trial.
Interleukin-1 blockade for the treatment of pericarditis.
Buckley LF, Viscusi MM, Van Tassell BW, Abbate A. Buckley LF, et al. Among authors: van tassell bw. Eur Heart J Cardiovasc Pharmacother. 2018 Jan 1;4(1):46-53. doi: 10.1093/ehjcvp/pvx018. Eur Heart J Cardiovasc Pharmacother. 2018. PMID: 28633474 Free PMC article. Review.
214 results